Matches in Nanopublications for { ?s ?p "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_assertion description "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_provenance.
- NP554039.RAEsliNpp68fL-gfmZ9N6pDacLFEra9Nqpp3lT9PocduE130_assertion description "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554039.RAEsliNpp68fL-gfmZ9N6pDacLFEra9Nqpp3lT9PocduE130_provenance.
- NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_assertion description "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_provenance.
- NP1050757.RAwBCormUdsnBNDHGYo13u36l7rsboR8Vl05wZyTkUbjM130_assertion description "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1050757.RAwBCormUdsnBNDHGYo13u36l7rsboR8Vl05wZyTkUbjM130_provenance.